Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Molecular Cancer Therapeutics
|
February 28, 2013
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoter
Daniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, et al.
International Journal of Colorectal Disease
|
December 3, 2025
Histological assessment of radiotherapy-induced injury in the anal canal: an exploratory study
Aikaterini Leventi, Paul Sibbons, Alexia Tsigka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2018
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort
Christopher M Jones, Richard Adams, Amy Downing, et al.
Gut
|
January 25, 2017
Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score
Nick J Battersby, George Bouliotis, Katrine J Emmertsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 24, 2015
Reirradiation of locally recurrent rectal cancer: a systematic review
Marianne Grønlie Guren, Christine Undseth, Bernt Louni Rekstad, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
"Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I)
Rob Glynne-Jones, David Sebag-Montefiore, Richard Adams, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2012
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin
David Sebag-Montefiore, Helen M Meadows, David Cunningham, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2008
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer
Rob Glynne-Jones, Helen Meadows, Susan Wan, et al.
Health Technology Assessment (Winchester, England)
|
April 15, 2025
Evaluation of prognostic models to improve prediction of metastasis in patients following potentially curative treatment for primary colorectal cancer: the PROSPECT trial
Vicky Goh, Susan Mallett, Manuel Rodriguez-Justo, et al.
The Lancet. Oncology
|
September 5, 2014
Guidance on the management of diarrhoea during cancer chemotherapy
Jervoise Andreyev, Paul Ross, Clare Donnellan, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Molecular Cancer Therapeutics
|
February 28, 2013
A phase II study of temozolomide in patients with advanced aerodigestive tract and colorectal cancers and methylation of the O6-methylguanine-DNA methyltransferase promoter
Daniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, et al.
International Journal of Colorectal Disease
|
December 3, 2025
Histological assessment of radiotherapy-induced injury in the anal canal: an exploratory study
Aikaterini Leventi, Paul Sibbons, Alexia Tsigka, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 4, 2018
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort
Christopher M Jones, Richard Adams, Amy Downing, et al.
Gut
|
January 25, 2017
Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score
Nick J Battersby, George Bouliotis, Katrine J Emmertsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 24, 2015
Reirradiation of locally recurrent rectal cancer: a systematic review
Marianne Grønlie Guren, Christine Undseth, Bernt Louni Rekstad, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
"Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I)
Rob Glynne-Jones, David Sebag-Montefiore, Richard Adams, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 4, 2012
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin
David Sebag-Montefiore, Helen M Meadows, David Cunningham, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2008
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer
Rob Glynne-Jones, Helen Meadows, Susan Wan, et al.
Health Technology Assessment (Winchester, England)
|
April 15, 2025
Evaluation of prognostic models to improve prediction of metastasis in patients following potentially curative treatment for primary colorectal cancer: the PROSPECT trial
Vicky Goh, Susan Mallett, Manuel Rodriguez-Justo, et al.
The Lancet. Oncology
|
September 5, 2014
Guidance on the management of diarrhoea during cancer chemotherapy
Jervoise Andreyev, Paul Ross, Clare Donnellan, et al.
Page
of 9